Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation.

Silva JM, Boczek NJ, Berres MW, Ma X, Smith DI.

RNA Biol. 2011 May-Jun;8(3):496-505. Epub 2011 May 1.

PMID:
21532345
2.

Long non-coding RNA LSINCT5 predicts negative prognosis and exhibits oncogenic activity in gastric cancer.

Xu MD, Qi P, Weng WW, Shen XH, Ni SJ, Dong L, Huang D, Tan C, Sheng WQ, Zhou XY, Du X.

Medicine (Baltimore). 2014 Dec;93(28):e303. doi: 10.1097/MD.0000000000000303.

3.

Long, abundantly expressed non-coding transcripts are altered in cancer.

Perez DS, Hoage TR, Pritchett JR, Ducharme-Smith AL, Halling ML, Ganapathiraju SC, Streng PS, Smith DI.

Hum Mol Genet. 2008 Mar 1;17(5):642-55. Epub 2007 Nov 15.

4.

Semaphorin-plexin signalling genes associated with human breast tumourigenesis.

Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.

Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2.

PMID:
21925246
5.

Identification of long stress-induced non-coding transcripts that have altered expression in cancer.

Silva JM, Perez DS, Pritchett JR, Halling ML, Tang H, Smith DI.

Genomics. 2010 Jun;95(6):355-62. doi: 10.1016/j.ygeno.2010.02.009. Epub 2010 Mar 7.

6.
7.

Sam68 up-regulation correlates with, and its down-regulation inhibits, proliferation and tumourigenicity of breast cancer cells.

Song L, Wang L, Li Y, Xiong H, Wu J, Li J, Li M.

J Pathol. 2010 Nov;222(3):227-37. doi: 10.1002/path.2751.

PMID:
20662004
8.

Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.

Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.

Clin Cancer Res. 2005 Jun 15;11(12):4357-64.

9.

EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer.

Giannini G, Ambrosini MI, Di Marcotullio L, Cerignoli F, Zani M, MacKay AR, Screpanti I, Frati L, Gulino A.

Mol Carcinog. 2003 Dec;38(4):188-200.

PMID:
14639658
10.

Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides.

Cooper C, Guo J, Yan Y, Chooniedass-Kothari S, Hube F, Hamedani MK, Murphy LC, Myal Y, Leygue E.

Nucleic Acids Res. 2009 Jul;37(13):4518-31. doi: 10.1093/nar/gkp441. Epub 2009 May 29.

11.

Proteome changes in ovarian epithelial cells derived from women with BRCA1 mutations and family histories of cancer.

Smith-Beckerman DM, Fung KW, Williams KE, Auersperg N, Godwin AK, Burlingame AL.

Mol Cell Proteomics. 2005 Feb;4(2):156-68. Epub 2004 Dec 9.

13.

The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.

Salceda S, Tang T, Kmet M, Munteanu A, Ghosh M, Macina R, Liu W, Pilkington G, Papkoff J.

Exp Cell Res. 2005 May 15;306(1):128-41.

PMID:
15878339
14.

Human cancer long non-coding RNA transcriptomes.

Gibb EA, Vucic EA, Enfield KS, Stewart GL, Lonergan KM, Kennett JY, Becker-Santos DD, MacAulay CE, Lam S, Brown CJ, Lam WL.

PLoS One. 2011;6(10):e25915. doi: 10.1371/journal.pone.0025915. Epub 2011 Oct 3.

15.

CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells.

Ioannidis P, Mahaira LG, Perez SA, Gritzapis AD, Sotiropoulou PA, Kavalakis GJ, Antsaklis AI, Baxevanis CN, Papamichail M.

J Biol Chem. 2005 May 20;280(20):20086-93. Epub 2005 Mar 14.

16.

Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.

Mercier PL, Bachvarova M, Plante M, Gregoire J, Renaud MC, Ghani K, TĂȘtu B, Bairati I, Bachvarov D.

Mol Oncol. 2011 Oct;5(5):438-53. doi: 10.1016/j.molonc.2011.07.003. Epub 2011 Jul 26.

17.

Expression of icb-1 gene is interferon-gamma inducible in breast and ovarian cancer cell lines and affects the IFN gamma-response of SK-OV-3 ovarian cancer cells.

Treeck O, Kindzorra I, Pauser K, Treeck L, Ortmann O.

Cytokine. 2005 Nov 3;32(3-4):137-42. Epub 2005 Oct 10.

PMID:
16219472
19.

Regulator of G-protein signalling expression and function in ovarian cancer cell lines.

Hurst JH, Mendpara N, Hooks SB.

Cell Mol Biol Lett. 2009;14(1):153-74. doi: 10.2478/s11658-008-0040-7. Epub 2008 Oct 31.

PMID:
18979070
20.

Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancers.

Carney ME, Maxwell GL, Lancaster JM, Gumbs C, Marks J, Berchuck A, Futreal PA.

J Soc Gynecol Investig. 1998 Sep-Oct;5(5):281-5.

PMID:
9773405
Items per page

Supplemental Content

Write to the Help Desk